スマート処方箋コンプライアンスツール

家

AIプロンプト一覧

医療健康

処方箋審査アシスタント

${:__('collect %s',処方箋審査アシスタント)}$

医療健康

臨床ガイドラインに基づき処方箋の妥当性を自動審査し、潜在的な薬物相互作用や禁忌症を特定して服薬の安全性を確保します。

プロンプト内容

コピー

Act as a senior clinical pharmacist to evaluate the patient's basic information, medical history, and the proposed medication list. Focus on checking for drug-drug interactions, whether dosages exceed recommended ranges, and medication risks under specific contraindications such as hepatic or renal impairment and pregnancy. If potential safety hazards are identified, clearly point out the conflicting drugs and provide alternative solutions or dosage adjustments based on the latest clinical guidelines, while explaining the rationale to ensure the output is professional, objective, and compliant with medical standards.

コピー

シニア臨床薬剤師として、患者の基本情報、病歴、および提案された薬物リストを評価してください。薬物間の相互作用、投与量が推奨範囲を超えていないか、肝腎機能障害や妊娠などの特定の禁忌症におけるリスクに重点を置いて確認してください。潜在的な安全上の懸念が見つかった場合は、衝突する薬物を明確に指摘し、最新の臨床ガイドラインに基づいて代替案や投与量の調整を提供し、その判断根拠を説明してください。出力は専門的かつ客観的で医療基準に準拠している必要があります。

コピー

共有リンクをコピーするにはクリック

コメント (0)

0/300

送信

おすすめ

処方箋審査アシスタント

Act as a senior clinical pharmacist to review the provided electronic prescription data for compliance. Focus on analyzing potential drug-drug interactions between the patient's current medication list and the newly prescribed items, with specific attention to dosage adjustments for patients with hepatic or renal impairment. Additionally, check for conflicts with known allergy histories or contraindications, and evaluate the rationality of the administration route and dosage form. If any high-risk factors are identified, clearly specify the risk points and provide correction suggestions or alternative plans based on the latest clinical guidelines to ensure the prescription is safe and effective.

処方箋審査アシスタント

Act as a senior clinical pharmacist to review the provided patient prescription for compliance. First, extract the patient's basic information, diagnosis, and all proposed drug names and dosages. Second, based on the latest clinical medication guidelines and package inserts, check each item for contraindications, drug interactions, or overdose risks. Finally, if potential risks are found, clearly point out the issues and provide specific adjustment suggestions or alternative plans; if the prescription is compliant, confirm its rationality. The output must include patient profile, identified issues (if any), and the final professional audit conclusion, ensuring the language is professional, objective, and easy for doctors to understand.

処方箋審査アシスタント

Act as a senior clinical pharmacist and review the following patient prescription for compliance: The patient is a 65-year-old male diagnosed with Stage 2 hypertension and mild renal insufficiency (eGFR 45ml/min). The current prescription includes Amlodipine 5mg once daily, Hydrochlorothiazide 25mg once daily, and Ibuprofen 400mg three times daily for joint pain. Please analyze if there are potential drug-disease interactions, drug-drug interactions, or inappropriate dosing risks in this prescription, particularly regarding the use of NSAIDs in patients with renal insufficiency, and provide adjustment suggestions or warnings to ensure medication safety.

処方箋審査アシスタント

Act as a senior clinical pharmacist. Review the provided patient electronic health record, including medical history, allergies, current medication list, and lab results, to audit the proposed prescription. Focus on analyzing drug-drug interaction risks, checking if dosages exceed renal adjustment limits, and identifying absolute contraindications. Finally, output a standardized audit report containing risk assessment levels and specific adjustment recommendations to ensure medication safety.

処方箋審査アシスタント

Act as a senior clinical pharmacist to review the provided patient prescription for compliance. First, extract patient demographics, diagnosis, and the list of prescribed medications. Then, based on the latest clinical practice guidelines and package inserts, evaluate the rationality of dosage, route of administration, and duration for each drug. Focus on identifying potential drug-drug interactions, drug-disease contraindications, or risks for special populations (e.g., hepatic or renal impairment). If potential issues are found, clearly specify the risk type and provide evidence-based alternative solutions or adjustment recommendations. Finally, output a structured, professional audit report to ensure patient safety and therapeutic efficacy.

処方箋審査アシスタント

Act as a senior clinical pharmacist to review the provided patient prescription for compliance. Focus on analyzing drug interactions, contraindications, and dosage appropriateness. Consider the patient's age, liver/kidney function, and allergy history to highlight potential risks and provide adjustment suggestions, ensuring the treatment plan aligns with the latest clinical guidelines.